Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about FDA
Recent news which mentions FDA
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
After FDA Delays Hemophilia Gene Therapy, BioMarin's Dwarfism Drug Under FDA Review For Expanded Use
March 08, 2023
Tickers
BBIO
BMRN
Tags
General
News
Market News
From
Benzinga
Mesoblast's Lead Drug Candidate Goes Under FDA Priority Review For Bone Marrow Transplant Complications In Kids
March 08, 2023
Tickers
MESO
Tags
News
General
Small Cap
From
Benzinga
Covis Pharma To Withdraw Only FDA-Approved Treatment To Prevent Preterm Births
March 08, 2023
Tickers
IBB
WBA
XLV
Tags
Briefs
News
General
From
Benzinga
FDA's Regulatory Delay is The Reason For Novavax, Lucira Health's Failure: WSJ Report
March 07, 2023
Tickers
LHDX
MRNA
NVAX
PFE
Tags
News
PFE
General
From
Benzinga
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
March 06, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Market News
Health Care
News
From
Benzinga
Why Veru Stock Is Crashing Today?
March 03, 2023
Tickers
VERU
Tags
FDA
Biotech
why it's moving
From
Benzinga
Despite Trial Failure Praxis Still Seeks Advancing Essential Tremor Program Into Phase 3 Study
March 03, 2023
Tickers
PRAX
Tags
Market News
Health Care
Movers
From
Benzinga
FDA Fuels Respiratory Syncytial Virus Vaccine Race While Backing GSK's Candidate Soon After Pfizer's
March 02, 2023
Tickers
GSK
PFE
Tags
News
PFE
General
From
Benzinga
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
March 01, 2023
Tickers
BBH
FBT
IBB
PBE
Tags
IBB
BBH
News
From
Benzinga
FDA AdComm Gives Thumbs Up To Pfizer's RSV Vaccine Candidate For Elderly People
March 01, 2023
Tickers
PFE
Tags
Health Care
Market News
News
From
Benzinga
FDA Rejects Cytokinetics' Heart Failure Treatment Candidate
March 01, 2023
Tickers
CYTK
Tags
Briefs
FDA
Biotech
From
Benzinga
FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles
March 01, 2023
Tickers
REGN
SNY
Tags
Health Care
Market News
SNY
From
Benzinga
Reata Pharmaceuticals Gets Price Target Bumps By Analysts Following FDA Approval Of Skyclarys
March 01, 2023
Tickers
RETA
Tags
Markets
Trading Ideas
Benzinga
From
Benzinga
Why Reata Pharma Shares Are Skyrocketing Today
March 01, 2023
Tickers
RETA
Tags
News
General
RETA
From
Benzinga
Why Reata Pharmaceuticals Shares Are Falling Monday?
February 27, 2023
Tickers
BIIB
RETA
Tags
RETA
BIIB
General
From
Benzinga
Lucira Health is Soaring Monday: Here Are The Details
February 27, 2023
Tickers
LHDX
Tags
Market News
Penny Stocks
Movers
From
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today